Training Level: Provider
Thursday, March 18th, 2021 from 2:00 – 3:00 PM Eastern
| VEKLURY® (remdesivir) is the first and only antiviral approved for the treatment of patients requiring hospitalization for COVID-19. Join us to find out more information on when and why this drug should be used for COVID-19 treatment. |
Register today: https://cutt.ly/Veklury-0321
Presenters:
Grayce Kim, Pharm.D.
Principal Medical Scientist
COVID-19
Gilead Sciences, Inc.
Recent Comments